Fampridine for Symptomatic Treatment in Chronic Inflammatory Demyelinating Polyneuropathy: A Randomized, Double‐Blinded, Placebo‐Controlled Crossover Study
Peter Nørregaard Hansen, Lars Markvardsen, Hatice Tankisi, Henning Andersen, Thomas Krøigård, Søren Sindrup. Fampridine for Symptomatic Treatment in Chronic Inflammatory Demyelinating Polyneuropathy: A Randomized, Double‐Blinded, Placebo‐Controlled Crossover Study. // Journal of the Peripheral Nervous System. – 2026. – DOI: 10.1111/jns.70172. – URL: https://onlinelibrary.wiley.com/doi/10.1111/jns.70172?af=R
Peter Nørregaard Hansen, Lars Markvardsen, Hatice Tankisi, Henning Andersen, Thomas Krøigård, & Søren Sindrup (2026). Fampridine for Symptomatic Treatment in Chronic Inflammatory Demyelinating Polyneuropathy: A Randomized, Double‐Blinded, Placebo‐Controlled Crossover Study. Journal of the Peripheral Nervous System. https://doi.org/10.1111/jns.70172
Peter Nørregaard Hansen, et al. “Fampridine for Symptomatic Treatment in Chronic Inflammatory Demyelinating Polyneuropathy: A Randomized, Double‐Blinded, Placebo‐Controlled Crossover Study.” Journal of the Peripheral Nervous System, 2026. doi:10.1111/jns.70172.
@article{Hansen2026,
title = {Fampridine for Symptomatic Treatment in Chronic Inflammatory Demyelinating Polyneuropathy: A Randomized, Double‐Blinded, Placebo‐Controlled Crossover Study},
author = {Hansen, Peter Nørregaard and Markvardsen, Lars and Tankisi, Hatice and Andersen, Henning and Krøigård, Thomas and Sindrup, Søren},
journal = {Journal of the Peripheral Nervous System},
year = {2026},
doi = {10.1111/jns.70172},
url = {https://onlinelibrary.wiley.com/doi/10.1111/jns.70172?af=R}
}